Walleye Capital’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-677,176
| Closed | -$4.16M | – | 4789 |
|
|
2025
Q4 | $4.16M | Buy |
677,176
+277,319
| +69% | +$2.01M | 0.02% | 1279 |
|
|
2025
Q3 | $2.89M | Buy |
399,857
+354,385
| +779% | +$2.1M | 0.02% | 1317 |
|
|
2025
Q2 | $241K | Sell |
45,472
-141,130
| -76% | -$834K | ﹤0.01% | 3217 |
|
|
2025
Q1 | $1.66M | Buy |
+186,602
| New | +$2.24M | 0.02% | 1562 |
|
|
2024
Q1 | – | Sell |
-17,228
| Closed | -$330K | – | 5792 |
|
|
2023
Q4 | $330K | Buy |
17,228
+16,907
| +5,267% | +$292K | ﹤0.01% | 3300 |
|
|
2023
Q3 | $5.15K | Buy |
+321
| New | +$6.11K | ﹤0.01% | 4584 |
|
|
2023
Q2 | – | Sell |
-26,149
| Closed | -$607K | – | 4956 |
|
|
2023
Q1 | $607K | Sell |
26,149
-12,977
| -33% | -$264K | 0.01% | 1550 |
|
|
2022
Q4 | $568K | Buy |
39,126
+17,880
| +84% | +$333K | 0.01% | 1363 |
|
|
2022
Q3 | $405K | Buy |
+21,246
| New | +$488K | 0.01% | 1612 |
|
|
2022
Q2 | – | Sell |
-15,852
| Closed | -$399K | – | 2606 |
|
|
2022
Q1 | $399K | Buy |
+15,852
| New | +$406K | 0.01% | 1128 |
|
|
2021
Q4 | – | Sell |
-7,381
| Closed | -$238 | – | 2246 |
|
|
2021
Q3 | $238 | Buy |
+7,381
| New | +$245K | 0.01% | 1128 |
|
|
2020
Q4 | – | Sell |
-46,114
| Closed | -$601K | – | 1053 |
|
|
2020
Q3 | $601K | Buy |
46,114
+24,288
| +111% | +$307K | 0.07% | 335 |
|
|
2020
Q2 | $248K | Sell |
21,826
-3,154
| -13% | -$44.8K | 0.06% | 375 |
|
|
2020
Q1 | $358K | Buy |
24,980
+24,722
| +9,582% | +$522K | 0.11% | 298 |
|
|
2019
Q4 | $7K | Buy |
258
+158
| +158% | +$4.35K | ﹤0.01% | 1666 |
|
|
2019
Q3 | $3K | Buy |
+100
| New | +$2.91K | ﹤0.01% | 1825 |
|
|
2019
Q2 | – | Sell |
-300
| Closed | -$10K | – | 2135 |
|
|
2019
Q1 | $10K | Buy |
+300
| New | +$9.13K | 0.01% | 1404 |
|
Other funds holding MYGN
O
GCM
VCM
VPM
